Literature DB >> 15640340

Annual risk of infection with Mycobacterium tuberculosis.

H Rieder1.   

Abstract

The average annual risk of infection with Mycobacterium tuberculosis is a calculated average from an observed prevalence of infection, approximating the incidence of infection. It has the potential to be informative about the extent of transmission in a community. Where serial surveys are available, secular trends in transmission might be ascertained. The prerequisite for calculating the average annual risk is the successful determination of the prevalence of infection. Difficulties arising with tuberculin skin-test surveys include logistical problems in sampling a representative portion of the population. Therefore, a compromise assesses the prevalence of infection among school children as an indicator of transmission in the community at large. The utilisation of tuberculin surveys is further compounded by the unpredictable specificity of the tuberculin skin test and, thus, the predictive value of a positive test result. Statistical approaches using mixture analysis may overcome this problem to some extent, but the experience is limited. Cytokine-derived assays, such as the interferon-gamma release assays, are promising in providing higher specificity, but they require venepuncture.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15640340     DOI: 10.1183/09031936.04.00103804

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  22 in total

1.  Improving the estimation of tuberculosis infection prevalence using T-cell-based assay and mixture models.

Authors:  M Pai; N Dendukuri; L Wang; R Joshi; S Kalantri; H L Rieder
Journal:  Int J Tuberc Lung Dis       Date:  2008-08       Impact factor: 2.373

2.  Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis.

Authors:  Simon J Tsiouris; David Coetzee; Patricia L Toro; Judy Austin; Zena Stein; Wafaa El-Sadr
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 3.  HIV and tuberculosis: a deadly human syndemic.

Authors:  Candice K Kwan; Joel D Ernst
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

4.  Integrating social contact and environmental data in evaluating tuberculosis transmission in a South African township.

Authors:  Jason R Andrews; Carl Morrow; Rochelle P Walensky; Robin Wood
Journal:  J Infect Dis       Date:  2014-03-08       Impact factor: 5.226

5.  Evaluation of QuantiFERON-TB gold in-tube and tuberculin skin tests among immigrant children being screened for latent tuberculosis infection.

Authors:  Meredith M Howley; John A Painter; Dolores J Katz; Edward A Graviss; Randall Reves; Suzanne F Beavers; Denise O Garrett
Journal:  Pediatr Infect Dis J       Date:  2015-01       Impact factor: 2.129

6.  The T2 Mycobacterium tuberculosis genotype, predominant in Kampala, Uganda, shows negative correlation with antituberculosis drug resistance.

Authors:  Deus Lukoye; Fred A Katabazi; Kenneth Musisi; David P Kateete; Benon B Asiimwe; Moses Okee; Moses L Joloba; Frank G J Cobelens
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

Review 7.  Paediatric tuberculosis.

Authors:  Sandra M Newton; Andrew J Brent; Suzanne Anderson; Elizabeth Whittaker; Beate Kampmann
Journal:  Lancet Infect Dis       Date:  2008-08       Impact factor: 25.071

8.  Problems in diagnosis and treatment of tuberculosis infection.

Authors:  V Tsara; E Serasli; P Christaki
Journal:  Hippokratia       Date:  2009-01       Impact factor: 0.471

9.  Rates of tuberculosis transmission to children and adolescents in a community with a high prevalence of HIV infection among adults.

Authors:  Keren Middelkoop; Linda-Gail Bekker; Landon Myer; Rodney Dawson; Robin Wood
Journal:  Clin Infect Dis       Date:  2008-08-01       Impact factor: 9.079

10.  Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa.

Authors:  Kwame Shanaube; Charalambos Sismanidis; Helen Ayles; Nulda Beyers; Ab Schaap; Katherine-Anne Lawrence; Annie Barker; Peter Godfrey-Faussett
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.